EP2373277B1 - Closure cap for receptacles for receiving medical liquids and receptacle for receiving medical liquids - Google Patents
Closure cap for receptacles for receiving medical liquids and receptacle for receiving medical liquids Download PDFInfo
- Publication number
- EP2373277B1 EP2373277B1 EP09818658.8A EP09818658A EP2373277B1 EP 2373277 B1 EP2373277 B1 EP 2373277B1 EP 09818658 A EP09818658 A EP 09818658A EP 2373277 B1 EP2373277 B1 EP 2373277B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- injection
- closure cap
- closure
- break
- recess
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims description 16
- 239000007924 injection Substances 0.000 claims description 85
- 238000002347 injection Methods 0.000 claims description 85
- 239000012528 membrane Substances 0.000 claims description 27
- 239000000654 additive Substances 0.000 claims description 18
- 230000000996 additive effect Effects 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 13
- 238000001802 infusion Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 5
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 239000012530 fluid Substances 0.000 description 9
- 239000003978 infusion fluid Substances 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000000071 blow moulding Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012859 sterile filling Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1418—Threaded type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1481—Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1487—Inlet or outlet ports with friction fit, e.g. connecting tubes directly to a protruding port
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/18—Arrangements for indicating condition of container contents, e.g. sterile condition
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D41/00—Caps, e.g. crown caps or crown seals, i.e. members having parts arranged for engagement with the external periphery of a neck or wall defining a pouring opening or discharge aperture; Protective cap-like covers for closure members, e.g. decorative covers of metal foil or paper
- B65D41/32—Caps or cap-like covers with lines of weakness, tearing-strips, tags, or like opening or removal devices, e.g. to facilitate formation of pouring openings
- B65D41/50—Caps or cap-like covers with membranes, e.g. arranged to be pierced
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D47/00—Closures with filling and discharging, or with discharging, devices
- B65D47/36—Closures with frangible parts adapted to be pierced, torn or removed, to provide discharge openings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1431—Permanent type, e.g. welded or glued
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
Definitions
- the 6 and 7 show an alternative embodiment of the closure cap 1 'according to the invention, which differs from that described with reference to FIGS Fig. 1 to 5 described cap differs only by the arrangement of the two Zuspritzmaschine and the removal part on the outer portion of the lid part. Therefore, the same reference numerals are used for the corresponding parts.
- the outer portion 5 of the cover part 2 of the closure cap 1 ' has a substantially rectangular shape with rounded corners.
- the two Zuspritzmaschine 6, 7 and the removal part 8 are arranged offset to one another. In this case, the first injection part 6 and the removal part 8 lie on one half and the second injection part 7 on the other half at the top of the outer portion 5 of the cover part 2.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Closures For Containers (AREA)
Description
Die Erfindung bezieht sich auf eine Verschlusskappe für Behältnisse zur Aufnahme von medizinischen Flüssigkeiten, insbesondere für mit Infusions- oder Transfusionslösungen oder Flüssigkeiten zur enteralen Ernährung befüllte Behältnisse. Darüber hinaus betrifft die Erfindung ein Behältnis zur Aufnahme von medizinischen Flüssigkeiten, insbesondere eine Flasche, mit einer derartigen Verschlusskappe.The invention relates to a closure cap for containers for holding medical fluids, in particular for filled with infusion or transfusion solutions or liquids for enteral nutrition containers. Moreover, the invention relates to a container for receiving medical fluids, in particular a bottle, with such a cap.
Als Blow-Fill-Seal-Verfahren (BFS-Verfahren) ist ein Verfahren bekannt, bei dem Behältnisse, beispielsweise Flaschen aus extrudiertem PE oder PP, in einem Arbeitsgang steril und pyrogenfrei in eine gewünschte Form geblasen und unmittelbar nach der Abkühlung mit einem sterilen Füllgut aseptisch befüllt und hermetisch verschlossen werden. Die nach dem Blasen-Füllen-Verschließen-Verfahren hergestellten Behältnisse, insbesondere Flaschen, werden auch aus BFS-Behältnisse bezeichnet.As a blow-fill-seal method (BFS method), a method is known in which containers, such as bottles of extruded PE or PP, in a single operation sterile and pyrogen-free blown into a desired shape and immediately after cooling with a sterile filling aseptically filled and hermetically sealed. The containers produced by the bubble-fill-seal method, in particular bottles, are also referred to as BFS containers.
Wenn die bekannten BFS-Behältnisse zur Aufnahme von sterilen, medizinischen Flüssigkeiten, beispielsweise Infusionslösungen eingesetzt werden, benötigen die Behältnisse eine Verschlusskappe, die ein Überführen der Infusionslösung mittels eines Infusionsgerätes zum Patienten erlaubt. Die Zugabe von Medikamenten in die Infusionslösung sollte ebenfalls möglich sein.When the known BFS containers are used to hold sterile medical fluids, for example infusion solutions, the containers require a closure cap which allows the infusion solution to be transferred to the patient by means of an infusion device. The addition of medication to the infusion solution should also be possible.
Aus der
Eine Verschlusskappe, die sowohl über einen Entnahmeteil zum Entnehmen von Flüssigkeit als auch einen Zuspritzteil zum Zuspritzen eines Additivs verfügt, ist auch aus der
Die aus der
Verschlusskappen für enterale Nährlösungen enthaltene Behältnisse sind auch aus der
Die
Zum Anschluss medizinischer Geräte sind in der Medizintechnik Kegelverbindungen mit einem Kegelschaft und einer Kegelhülse bekannt, deren Kegelflächen normiert sind. Die nicht verriegelbaren Kegelverbindungen mit normierten Kegelflächen werden als Luer-Konnektoren und die verriegelbaren Kegelverbindungen als Luer-Lock Konnektoren bezeichnet. So sind auch Luer-Spritzen ohne Schraubverbindungen und Luer-Lock-Spritzen mit Schraubverbindungen bekannt.For connection of medical devices, conical connections with a conical shank and a conical sleeve are known in medical technology whose conical surfaces are normalized. The Non-lockable conical connections with normalized conical surfaces are referred to as Luer connectors and the lockable conical connections as Luer-Lock connectors. Luer syringes without screw connections and Luer lock syringes with screw connections are also known.
Der Erfindung liegt Aufgabe zugrunde, eine Verschlusskappe für Behältnisse zur Aufnahme von medizinischen Flüssigkeiten, insbesondere für mit Infusions- oder Transfüsionslösungen oder Flüssigkeiten zur enteralen Ernährung befüllt Behältnisse zu schaffen, die besonders einfach zu handhaben ist und universell einsetzbar ist. Darüber hinaus ist eine Aufgabe der Erfindung, ein Behältnis zur Aufnahme von medizinischen Flüssigkeiten, insbesondere eine Flasche, zu schaffen, die sich einfach handhaben und universell einsetzen lässt.The invention has for its object to provide a cap for containers for receiving medical fluids, especially for infused with infusion or Transfüsionslösungen or liquids for enteral nutrition containers that is particularly easy to handle and is universally applicable. Moreover, it is an object of the invention to provide a container for containing medical fluids, in particular a bottle, which is easy to handle and universally applicable.
Die Lösung dieser Aufgaben erfolgt erfindungsgemäß mit den in den Patentansprüchen 1 und 17 angegebenen Merkmalen. Bevorzugte Ausführungsformen der Erfindung sind Gegenstand der Unteransprüche.The solution of these objects is achieved according to the invention with the features specified in the
Die erfindungsgemäße Verschlusskappe zeichnet sich durch zwei getrennt voneinander angeordnete Zuspritzteile jeweils zum Zuspritzen eines Additivs aus. Der eine Zuspritzteil dient zum Zuspritzen eines Additivs mit einer nadellosen Injektionsspritze, während der andere Zuspritzteil zum Zuspritzen eines Additivs mit einer Injektionsspritze dient, die eine Nadel (Kanüle) aufweist. Daher ist es möglich, der in dem Behältnis enthaltenen medizinischen Flüssigkeit unterschiedliche Additive sowohl mit einer nadellosen Injektionsspritze als auch einer Injektionsspritze mit Nadel zuzuspritzen. Damit ist die erfindungsgemäße Verschlusskappe universell einsetzbar.The closure cap according to the invention is characterized by two injection parts arranged separately from one another, in each case for injecting an additive. The one injection part is used for injecting an additive with a needleless injection syringe, while the other injection part is used for injecting an additive with a syringe having a needle (cannula). Therefore, it is possible to inject various additives into the medical fluid contained in the container with both a needleless syringe and a hypodermic needle syringe. Thus, the closure cap according to the invention is universally applicable.
Wenn beispielsweise ein erstes Additiv über den ersten Zuspritzteil zugespritzt worden ist, kann ein zweites Additiv über den zweiten Zuspritzteil zugespritzt werden. Vorzugsweise sind beide Zuspritzteile mit einem Abbrechteil dicht verschlossen. Sollte der Abbrechteil des einen Zuspritzteils abgebrochen sein, bleibt der andere Zuspritzteil weiterhin von dem noch nicht abgebrochenen Abbrechteil geschützt. Dies hat den Vorteil, dass der noch nicht benutzte Zuspritzteil nicht verunreinigt werden kann.For example, if a first additive has been injected via the first injection part, a second additive may be injected via the second injection part. Preferably, both injection parts are sealed tightly with a break-off part. Should the break-off part of one injection part be broken off, the other injection part continues to be protected by the break-off part which has not yet been broken off. This has the advantage that the not yet used Zuspritzteil can not be contaminated.
Bei einer bevorzugten Ausführungsform weist die Verschlusskappe einen Deckelteil und einen Randteil auf, wobei der Deckelteil einen inneren Abschnitt und einen äußeren Abschnitt aufweist, der von dem inneren Abschnitt nach außen vorsteht. Der erste und zweite Zuspritzteil sowie der Entnahmeteil sind vorzugsweise an dem äußeren nach außen vorstehenden Abschnitt des Deckelteils angeordnet. Somit springen die Zuspritzstelle und die Entnahmestelle nach außen vor, so dass die Zuspritzstellen und die Entnahmestelle an der Verschlusskappe leicht zugänglich sind.In a preferred embodiment, the closure cap has a lid portion and a rim portion, the lid portion having an inner portion and an outer portion projecting outwardly from the inner portion. The first and second injection part and the extraction part are preferably arranged on the outer outwardly projecting portion of the lid part. Thus, the injection point and the extraction point jump outwards so that the injection points and the removal point on the closure cap are easily accessible.
Der erste und zweite Zuspritzteil und der Entnahmeteil sind bei einer bevorzugten Ausführungsform an dem äußeren Abschnitt des Deckelteils in einer Reihe vorzugsweise dicht nebeneinander liegend angeordnet. Dabei sollte sich der äußere Abschnitt des Deckelteils möglichst über die gesamte Breite des Deckelteils erstrecken. Damit steht ausreichend Platz für die Anordnung der Zuspritzteile und des Entnahmeteils zur Verfügung.The first and second injection part and the removal part are preferably arranged in a preferred embodiment on the outer portion of the lid part in a row preferably close to each other. In this case, the outer portion of the cover part should extend as far as possible over the entire width of the cover part. This is sufficient space for the arrangement of Zuspritzteile and the sampling part available.
Eine alternative Ausführungsform sieht eine versetzte Anordnung der Zuspritzteile und des Entnahmeteils an dem äußeren Abschnitt des Deckelteils vor. Bei dieser alternativen Ausführungsform hat der nach außen vorstehende Abschnitt des Deckelteils vorzugsweise eine im Wesentlichen rechteckförmige Form, so dass ausreichend Platz für die Zuspritzteile und den Entnahmeteil zur Verfügung steht.An alternative embodiment provides an offset arrangement of the injection parts and the removal part on the outer portion of the cover part. In this alternative embodiment, the outwardly projecting portion of the lid portion preferably has a substantially rectangular shape so that there is sufficient space for the injection portions and the extraction portion.
Die Abbrechteile zum Verschließen der Zuspritzteile und des Entnahmeteils weisen vorzugsweise seitliche Grifflaschen auf, die sich vorzugsweise über den äußeren Abschnitt des Deckelteils erstrecken. Dadurch lassen sich die Grifflaschen leicht von der Seite greifen.The break off parts for closing the injection parts and the removal part preferably have lateral grip tabs, which preferably extend over the outer part of the cover part. This allows the grip tabs to be easily grabbed from the side.
Der Zuspritzteil für die nadellose Injektionsspritze weist einen nach außen weisenden Anschlussteil mit einer Ausnehmung zur Aufnahme des Kegelschaftes der Spritze und einen nach innen weisenden Verschlussteil auf, in dem eine selbst abdichtende Membran angeordnet ist. Der nach außen weisende Anschlussteil des ersten Zuspritzteils weist vorzugsweise ein Außengewinde auf, so dass eine bekannte Luer-Lock-Spritze an den Anschlussteil angeschlossen werden kann. Es ist aber auch möglich, dass der Anschlussteil des Zuspritzteils kein Außengewinde aufweist, so dass nur der Anschluss einer bekannten Luer-Spritze möglich ist.The injection part for the needleless injection syringe has an outwardly facing connecting part with a recess for receiving the conical shank of the syringe and an inwardly facing closure part, in which a self-sealing membrane is arranged. The outwardly pointing connection part of the first injection part preferably has an external thread, so that a known Luer-lock syringe can be connected to the connection part. But it is also possible that the connection part the Zuspritzteils has no external thread, so that only the connection of a known Luer syringe is possible.
Das erfindungsgemäße Behältnis, insbesondere Infusions- oder Transfusionsbehältnis oder Behältnis zur Aufnahme einer enteralen Nährlösung, ist vorzugsweise als Flasche, insbesondere SBM-Flasche (SBM: Stretch-Blow-Moulding) ausgebildet, die mit der erfindungsgemäßen Verschlusskappe verschlossen ist.The container according to the invention, in particular infusion or transfusion container or container for receiving an enteral nutrient solution, is preferably designed as a bottle, in particular SBM bottle (SBM: Stretch Blow Molding), which is closed with the closure cap according to the invention.
Im Folgenden werden zwei Ausführungsbeispiele der Erfindung unter Bezugnahme auf die Zeichnungen näher erläutert.In the following, two embodiments of the invention will be explained in more detail with reference to the drawings.
Es zeigen:
- Fig. 1
- Ein Ausführungsbeispiel der erfindungsgemäßen Verschlusskappe in der Draufsicht, bei der die Zuspritzteile und der Entnahmeteil in Reihe angeordnet sind,
- Fig. 2
- die Verschlusskappe von
Fig. 1 in der Unteransicht, - Fig. 3
- die Verschlusskappe von
Fig. 1 in geschnittener Darstellung, wobei der Abbrechteil von einem Zuspritzteil abgebrochen ist, um ein Additiv mit einer Spritze zuzuspritzen, die eine Nadel aufweist, - Fig. 4
- die Verschlusskappe von
Fig. 1 in geschnittener Darstellung, wobei der Abbrechteil von dem anderen Zuspritzteil abgebrochen ist, um ein Additiv mit einer nadellosen Spritze zuzuspritzen, - Fig. 5
- die Verschlusskappe von
Fig. 1 in geschnittener Darstellung, wobei der Abbrechteil von dem Entnahmeteil zur Entnahme von Flüssigkeit mit einen Spike abgebrochen ist, - Fig. 6
- ein zweites Ausführungsbeispiel der erfindungsgemäßen Verschlusskappe in der Ansicht von oben, bei der die Zuspritzteile und der Entnahmeteil versetzt zueinander angeordnet sind,
- Fig. 7
- die Verschlusskappe von
Fig. 6 in der Ansicht von unten und - Fig. 8
- ein Ausführungsbeispiel eines erfindungsgemäßen Behältnisses mit einer erfindungsgemäßen Verschlusskappe.
- Fig. 1
- An embodiment of the closure cap according to the invention in plan view, in which the injection parts and the removal part are arranged in series,
- Fig. 2
- the cap of
Fig. 1 in the bottom view, - Fig. 3
- the cap of
Fig. 1 in a sectional view, wherein the break-off part is broken off from an injection part to inject an additive with a syringe having a needle, - Fig. 4
- the cap of
Fig. 1 in a sectional view, wherein the break-off part is broken off from the other injection part to inject an additive with a needleless syringe, - Fig. 5
- the cap of
Fig. 1 in a sectional representation, wherein the break-off part is broken off from the removal part for taking out liquid with a spike, - Fig. 6
- A second embodiment of the closure cap according to the invention in the view from above, in which the injection parts and the removal part are arranged offset from one another,
- Fig. 7
- the cap of
Fig. 6 in the view from below and - Fig. 8
- An embodiment of a container according to the invention with a closure cap according to the invention.
Die
Die Verschlusskappe 1 weist einen Deckelteil 2 und einen Randteil 3 auf. Der Deckelteil 2 weist einen flachen inneren Abschnitt 4 auf, von dem ein äußerer Abschnitt 5 nach außen vorsteht. Der äußere Abschnitt 5 des Deckelteils 2 hat eine langgestreckte Form mit zwei im Wesentlichen gradlinigen Abschnitten 5A, an die sich zu beiden Seiten im Wesentlichen halbkreisförmige Abschnitte 5B anschließen. Der äußere Abschnitt 4 erstreckt sich über die gesamte Breite des inneren Abschnitts 4 des Deckelteils 2. An der Oberseite des äußeren Abschnitts 5 des Deckelteils 2 befinden sich für den Benutzer leicht zugänglich ein erster Zuspritzteil 6, ein zweiter Zuspritzteil 7 und ein Entnahmeteil 8. Der erste Zuspritzteil 6 dient zum Zuspritzen eines Additivs mit einer Injektionsspritze, die eine Nadel aufweist (
Die beiden Zuspritzteile 6 und 7 sowie der Entnahmeteil 8 sind an dem äußeren Abschnitt 5 des Deckelteils 2 dicht nebeneinander liegend in Reihe angeordnet. Dabei liegen sie auf einer Achse 9, die der Längsachse des äußeren Abschnitts 5 des Deckelteils 2 entspricht. Die beiden Zuspritzteile 6 und 7, die einen kleineren Durchmesser als der Entnahmeteil 8 haben, sind dicht nebeneinander liegend angeordnet, während der Entnahmeteil 8 dicht neben den beiden Zuspritzteilen 6, 7 liegt.The two Zuspritzteile 6 and 7 and the
Nachfolgend werden unter Bezugnahme auf die
Der erste Zuspritzteil 6 am äußeren Rand des Deckelteils 2 zum Zuspritzen eines Additivs mit einer Injektionsspritze (
Von dem ringförmigen Abschnitt 10 des ersten Zuspritzteils 6 weist ein Verschlussteil 16 nach innen, der eine Ausnehmung 17 aufweist. In der Ausnehmung 17 des Verschlussteils 16 ist eine durchstechbare, selbstabdichtende Membran 18 eingesetzt. Die Membran 18 ist dabei einschnappend in der Ausnehmung 16 festgelegt. Die Ausnehmung 17 weist einen oberen zylindrischen Abschnitt 16A auf, der sich an den ringförmigen Abschnitt 10 des ersten Zuspritzteils 6 anschließt. An den oberen zylindrischen Abschnitt 16A schließt sich ein unterer zylindrischer Abschnitt 16B an, der einen größeren Innendurchmesser als der obere zylindrische Abschnitt 16A hat. Die selbstabdichtende Membran 18 weist entsprechend einen unteren zylindrischen Abschnitt 18A mit einem größeren Außendurchmesser auf, der in dem unteren zylindrischen Abschnitt 16B der Ausnehmung 16 sitzt. An den unteren zylindrischen Abschnitt 18A der Membran 18 schließt sich ein oberer zylindrischer Abschnitt 18B mit einem kleineren Außendurchmesser an, der passend in dem oberen zylindrischen Abschnitt 16A der Ausnehmung 17 sitzt.Of the
Zur klemmenden Fixierung der Membran 18 in der Ausnehmung 17 weist der Verschlussteil 16 einen nach innen vorspringenden Rand 19 am unteren Ende des Verschlussteils 16 auf, der die Membran 18 untergreift. Die Membran 18 hat eine flache Ober- und Unterseite und ist nicht geschlitzt. Dadurch wird erreicht, dass die Membran nach dem Herausziehen der Kanüle einer Injektionsspritze wieder sicher abdichtet und keine Flüssigkeit ausläuft.For clamping fixation of the
Der zweite Zuspritzteil 7 der mittig angeordnet ist, verfügt über einen nach außen weisenden Anschlussteil 20 zum Anschluss einer nadellosen Luer-Lock-Spritze (
Der zweite Zuspritzteil 7 weist auch einen Verschlussteil 26 auf, der dem Verschlussteil 16 der ersten Zuspritzstelle 6 entspricht. Der Verschlussteil 26 der zweiten Zuspritzstelle weist wieder eine Ausnehmung 27 auf, in der eine Membran 28 klemmend fixiert ist. Der Verschlussteil 26 des zweiten Zuspritzteils 7 unterscheidet sich von dem Verschlussteil des ersten Zuspritzteils 6 durch die Membran 28, die einen unteren ringförmigen Abschnitt 28A aufweist, an den sich über einen mittleren Steg 28B ein oberer tellerförmiger Abschnitt 28C anschließt, der eine muldenförmige Vertiefung 28D aufweist. Der tellerförmige Abschnitt 28C der Membran 28 ist mit einem oder mehreren Schlitzen versehen, beispielsweise kreuzweise geschlitzt.The
Der Entnahmeteil 8 der Verschlusskappe 1 weist einen nach außen weisende Anschlussteil 29 zum Anschluss des Spike eines Infusionsgeräts auf (
Der Entnahmeteil 8 weist einen nach innen vorspringenden Verschlussteil 34 mit einer Ausnehmung 35 auf, in der wieder eine durchstechbare, selbstabdichtende Membran 36 klemmend fixiert ist. Die selbstabdichtende Membran 36 des Entnahmeteils 8 weist einen äußeren ringförmigen oberen Abschnitt 36A auf, an den sich über einen mittleren Steg 36B ein tellerförmiger unterer Abschnitt 36C anschließt. Der mittlere Steg 36B der Membran 36 wird von einem nach innen vorspringenden Rand 37 am unteren Ende des Verschlussteils 34 klemmend gehalten.The
Die Verschlusskappe 1 weist am unteren Rand des Randteils 3 einen wulstförmigen Rand 38 auf, der an der Unterseite eine umlaufende Nut 39 hat. Die Verschlusskappe kann auf eine Flasche aufgesetzt werden, wobei der obere Rand des Flaschenhalses in die Nut 29 des wulstförmigen Rands 38 der Verschlusskappe 1 greift.The
Nachfolgend wird die Handhabung der Verschlusskappe 1 beschrieben.Hereinafter, the handling of the
Zum Entnehmen einer Flüssigkeit, beispielsweise einer Infusionslösung wird der Abbrechteil 31 von der Verschlusskappe 1 abgebrochen, so dass die Membran 36 des Entnahmeteils 8 freiliegt. Dann wird der Spike des Infusionsgeräts an den Anschlussteil 29 des Entnahmeteils 8 angeschlossen (
Die
Claims (17)
- A closure cap for receptacles for receiving medical liquids, in particular for receptacles filled with infusion or transfusion solutions or liquids for enteral nutrition, with
a withdrawal part (8) for withdrawing the medical liquid using a spike, wherein the removal part (8) has an outwardly directed connector part (29), with a recess (30) for receiving the spike, and an inwardly directed closure part (34), in which a self-sealing membrane (36) is arranged with which the recess (30) of the withdrawal part (8) is closed, and
an injection part (7) separate from the withdrawal part (8) and designed for injecting an additive into the medical liquid using a needleless injection syringe, wherein the injection part (7) has an outwardly directed connector part (20), with a recess (20A) for receiving the conical stem of the syringe, and an inwardly directed closure part (26), in which a self-sealing membrane (28) is arranged with which the recess (20A) of the injection part (7) is closed,
characterized in that
the closure cap has a second injection part (6) separate from the first injection part (7) and designed for injecting an additive into the medical liquid using an injection syringe that has a needle, wherein the second injection part (6) has an inwardly directed closure part (16), with a recess (17) in which a self-sealing membrane (18) is arranged with which the recess (17) of the closure part (16) is closed. - The closure cap as claimed in claim 1, characterized in that the closure cap has a lid part (2) and an edge part (3), wherein the lid part (2) has an inner portion (4) and an outer portion (5) protruding outward from the inner portion.
- The closure cap as claimed in claim 2, characterized in that the first and second injection parts (6, 7) and the withdrawal part (8) are arranged lying next to one another in a row on the outer portion (5) of the lid part (2).
- The closure cap as claimed in claim 2, characterized in that the first and second injection parts (6, 7) and the withdrawal part (8) are arranged offset in relation to one another on the outer portion (5) of the lid part (2).
- The closure cap as claimed in one of claims 1 through 4, characterized in that the connector part (20) of the first injection part (7) has an outer thread (20B).
- The closure cap as claimed in one of claims 1 through 5, characterized in that the connector part (20) of the first injection part (7) is closed with a break-off part (21), which is attached to the connector part (20) of the first injection part (7) via an annular break zone (22).
- The closure cap as claimed in claim 6, characterized in that the break-off part (21) of the connector part (20) of the first injection part (7) has a lateral grip tab (25), which extends across the outer portion (5) of the lid part (2).
- The closure cap as claimed in one of claims 1 through 7, characterized in that the second injection part (6) has an outwardly directed annular shoulder (10), which is closed with a break-off part (11) attached to the annular shoulder (10) of the second injection part (6) via an annular break zone (12).
- The closure cap as claimed in claim 8, characterized in that the break-off part (11) of the second injection part (6) has a lateral grip tab (15), which extends across the outer portion (5) of the lid part (2).
- The closure cap as claimed in one of claims 1 through 9, characterized in that the closure part (26) of the first injection part (7) and/or the closure part (16) of the second injection part (6) and/or the closure part (34) of the withdrawal part (8) has an inwardly projecting edge (19, 37), which fixes and clamps the-self-sealing membrane of the closure part of the first and second injection parts and of the withdrawal part in the recess, respectively.
- The closure cap as claimed in one of claims 1 through 10, characterized in that the recess (16) of the first and second injection parts (7, 6) in each case has a first cylindrical upper portion (16A) and, adjoining the first cylindrical portion, a second cylindrical lower portion (16B), wherein the second cylindrical portion has a greater diameter than the first cylindrical portion.
- The closure cap as claimed in claim 11, characterized in that the self-sealing membrane (28) of the first injection part (7) has an annular lower portion (28A), which is arranged in the second cylindrical portion of the recess, and a plate-shaped upper portion (18C), which adjoins the annular portion via a central web (28B) and is arranged in the first cylindrical portion.
- The closure cap as claimed in one of claims 1 through 12, characterized in that the self-stealing membrane (28) of the first injection part (7) has a cup-shaped depression (28D).
- The closure cap as claimed in one of claims 1 through 13, characterized in that the self-sealing membrane (36) of the withdrawal part (8) has an outer annular upper portion (36A), to which a plate-shaped lower portion (36C) is adjoined via a central web (36B), wherein the outer annular portion of the membrane is held with a clamping action.
- The closure cap as claimed in one of claims 1 through 14, characterized in that the connector part (29) of the withdrawal part (8) is closed with a break-off part (31), which is attached to the connector part (29) of the withdrawal part (8) via an annular break-off zone (32).
- The closure cap as claimed in claim 15, characterized in that the break-off part (31) of the withdrawal part (8) has a lateral grip tab (33), which extends across the outer portion (5) of the lid part (2).
- A receptacle, in particular a bottle, having a closure cap as claimed in one of claims 1 through 16.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE200810060864 DE102008060864A1 (en) | 2008-12-09 | 2008-12-09 | Cap for containers for holding medical fluids and container for holding medical fluids |
PCT/EP2009/008622 WO2010066373A1 (en) | 2008-12-09 | 2009-12-03 | Closure cap for receptacles for receiving medical liquids and receptacle for receiving medical liquids |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2373277A1 EP2373277A1 (en) | 2011-10-12 |
EP2373277B1 true EP2373277B1 (en) | 2015-01-28 |
Family
ID=42145621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09818658.8A Active EP2373277B1 (en) | 2008-12-09 | 2009-12-03 | Closure cap for receptacles for receiving medical liquids and receptacle for receiving medical liquids |
Country Status (12)
Country | Link |
---|---|
US (2) | US8585674B2 (en) |
EP (1) | EP2373277B1 (en) |
KR (1) | KR20110101193A (en) |
CN (1) | CN102292062B (en) |
BR (1) | BRPI0923244A2 (en) |
CA (1) | CA2746202C (en) |
DE (1) | DE102008060864A1 (en) |
EA (1) | EA020842B1 (en) |
ES (1) | ES2531103T3 (en) |
HK (1) | HK1164109A1 (en) |
MX (1) | MX2011006139A (en) |
WO (1) | WO2010066373A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2881101B1 (en) * | 2011-11-11 | 2017-10-18 | Chongqing Lummy Pharmaceutical Co., Ltd. | Integrated medicine mixing interface |
EP2662303A1 (en) * | 2012-05-09 | 2013-11-13 | B. Braun Melsungen AG | Closure cap |
DE102012109194A1 (en) | 2012-09-27 | 2014-04-17 | B. Braun Avitum Ag | Tamper-evident closure for use on a container, container therewith and port for location on the container |
KR101362821B1 (en) * | 2012-11-07 | 2014-02-13 | 대한약품공업 주식회사 | Infusion solution container provided with hole for inserting spike of injection set |
EP2735300A1 (en) | 2012-11-26 | 2014-05-28 | Becton Dickinson France | Adaptor for multidose medical container |
DE102013105761A1 (en) * | 2013-06-04 | 2014-12-04 | Krones Ag | Closure for beverage bottle with possibility to supply gaseous medium |
CN103919680B (en) * | 2013-12-02 | 2016-01-20 | 江阴市鸿萌橡塑制品有限公司 | A kind of no-needle transfusion combined sealed cap |
EP3034062B1 (en) * | 2014-12-19 | 2017-03-22 | Fresenius Kabi Deutschland GmbH | Connector system comprising at least two outlet ports |
CN107405256B (en) * | 2015-03-27 | 2020-11-27 | 费森尤斯卡比德国有限公司 | Closure cap for a container for medical liquids |
CA2986496C (en) | 2015-05-22 | 2024-06-11 | Fresenius Kabi Deutschland Gmbh | Connection assembly for directing a medical liquid |
US11883364B2 (en) | 2015-05-22 | 2024-01-30 | Fresenius Kabi Deutschland Gmbh | Connection assembly for directing a medical liquid |
NL2016005B1 (en) | 2015-12-22 | 2017-07-03 | Scholle Ipn Ip Bv | Needleless syringe connector cap. |
DE102016003253A1 (en) * | 2016-03-16 | 2017-09-21 | Braunform Gmbh | Modular and adaptable cap for containers. |
WO2018060333A1 (en) | 2016-09-28 | 2018-04-05 | Fresenius Kabi Deutschland Gmbh | Sealing cap for a container for holding a medical liquid |
DE102016012059A1 (en) * | 2016-10-08 | 2018-04-12 | Fresenius Kabi Deutschland Gmbh | Connector for a liquid containing medical packaging |
DE102017000048A1 (en) * | 2017-01-05 | 2018-07-05 | Kocher-Plastik Maschinenbau Gmbh | container |
DE102017002401A1 (en) * | 2017-03-07 | 2018-09-13 | Kocher-Plastik Maschinenbau Gmbh | Plastic container product |
CN208770405U (en) * | 2017-12-26 | 2019-04-23 | 雷诺丽特恒迅包装科技(北京)有限公司 | Combination cover for transfusion |
CN209204063U (en) * | 2018-09-26 | 2019-08-06 | 雷诺丽特恒迅包装科技(北京)有限公司 | Combination cover for transfusion |
TWI709400B (en) * | 2020-01-08 | 2020-11-11 | 林忠信 | Liquid medicine tank |
USD961769S1 (en) * | 2020-05-22 | 2022-08-23 | Kpr U.S., Llc | Fluid connector |
DE102020208146A1 (en) * | 2020-06-30 | 2021-12-30 | B. Braun Melsungen Aktiengesellschaft | Cap for medical fluid container, attachment part for cap, system comprising cap and attachment part, medical fluid container, system comprising medical fluid container and attachment part, method for producing a fluid container |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US125522A (en) | 1872-04-09 | Improvement in photographic backgrounds | ||
US2442983A (en) * | 1942-08-14 | 1948-06-08 | Baxter Laboratories Inc | Closure |
DE1115890B (en) * | 1955-07-02 | 1961-10-26 | Dr Med Habil Jakob Clemens | Medical bottle with closure body and screw cap for sterile storage and / or transfer of blood, blood serum or the like. |
DE8308416U1 (en) * | 1983-03-22 | 1983-06-01 | Hansen, Gerhard, 7166 Sulzbach-Laufen | Zipper for a container |
DE3310265A1 (en) | 1983-03-22 | 1984-09-27 | Gerhard 7166 Sulzbach-Laufen Hansen | ZIPPER FOR A CONTAINER |
US5125522A (en) | 1988-12-22 | 1992-06-30 | Abbott Laboratories | Enteral delivery set assembly |
US4951845A (en) | 1989-01-17 | 1990-08-28 | Abbott Laboratories | Closure with filter |
DE9317644U1 (en) * | 1993-11-18 | 1994-01-27 | Pharma-Gummi Wimmer West GmbH, 52249 Eschweiler | Sealing cap |
DE19500460A1 (en) * | 1995-01-10 | 1996-07-11 | Pohl Gmbh & Co Kg | Arrangement on infusion bottles or the like |
US7678097B1 (en) * | 1999-11-12 | 2010-03-16 | Baxter International Inc. | Containers and methods for manufacturing same |
DE102004051300C5 (en) | 2004-10-20 | 2013-01-24 | Fresenius Kabi Deutschland Gmbh | Cap for containers filled with medical fluids |
US7488311B2 (en) * | 2004-12-23 | 2009-02-10 | Hospira, Inc. | Port closure system for intravenous fluid container |
US20060243759A1 (en) | 2005-04-28 | 2006-11-02 | King Daniel L | One-piece multiorifice closure |
US20080172022A1 (en) * | 2007-01-11 | 2008-07-17 | Biorep Technologies, Inc. | Infusion container |
DE102007005407A1 (en) | 2007-02-03 | 2008-08-07 | Fresenius Kabi Deutschland Gmbh | Cap for a container for holding medical fluids and container for receiving medical fluids |
DE102008048988A1 (en) * | 2008-09-25 | 2010-04-08 | Fresenius Kabi Deutschland Gmbh | Device for connecting a syringe to a container or a hose line |
-
2008
- 2008-12-09 DE DE200810060864 patent/DE102008060864A1/en not_active Withdrawn
-
2009
- 2009-12-03 BR BRPI0923244A patent/BRPI0923244A2/en not_active IP Right Cessation
- 2009-12-03 CA CA2746202A patent/CA2746202C/en active Active
- 2009-12-03 WO PCT/EP2009/008622 patent/WO2010066373A1/en active Application Filing
- 2009-12-03 EP EP09818658.8A patent/EP2373277B1/en active Active
- 2009-12-03 MX MX2011006139A patent/MX2011006139A/en active IP Right Grant
- 2009-12-03 EA EA201170785A patent/EA020842B1/en not_active IP Right Cessation
- 2009-12-03 KR KR20117015757A patent/KR20110101193A/en active IP Right Grant
- 2009-12-03 CN CN200980155134.8A patent/CN102292062B/en active Active
- 2009-12-03 US US13/133,674 patent/US8585674B2/en active Active
- 2009-12-03 ES ES09818658T patent/ES2531103T3/en active Active
-
2012
- 2012-05-15 HK HK12104727.8A patent/HK1164109A1/en unknown
-
2013
- 2013-11-18 US US14/082,312 patent/US9615996B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX2011006139A (en) | 2011-08-17 |
WO2010066373A1 (en) | 2010-06-17 |
US20140076839A1 (en) | 2014-03-20 |
EP2373277A1 (en) | 2011-10-12 |
ES2531103T3 (en) | 2015-03-10 |
KR20110101193A (en) | 2011-09-15 |
US9615996B2 (en) | 2017-04-11 |
HK1164109A1 (en) | 2012-09-21 |
EA201170785A1 (en) | 2012-01-30 |
CA2746202A1 (en) | 2010-06-17 |
CN102292062A (en) | 2011-12-21 |
DE102008060864A1 (en) | 2010-06-10 |
EA020842B1 (en) | 2015-02-27 |
US8585674B2 (en) | 2013-11-19 |
CN102292062B (en) | 2014-04-02 |
BRPI0923244A2 (en) | 2016-01-26 |
US20110245796A1 (en) | 2011-10-06 |
CA2746202C (en) | 2016-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2373277B1 (en) | Closure cap for receptacles for receiving medical liquids and receptacle for receiving medical liquids | |
EP2114345B1 (en) | Closure cap for a container for receiving medical liquids, and container for receiving medical liquids | |
EP1802535B1 (en) | Closing cap for containers filled with medical liquids | |
EP2301622B1 (en) | Connector for packaging containing medical fluids and packaging for medical fluids | |
DE69826691T2 (en) | CONTAINER CLOSURE WITH A BREAKABLE SEAL AND CONNECTION FOR A FLUID TRANSFER DEVICE | |
DE102008048988A1 (en) | Device for connecting a syringe to a container or a hose line | |
EP2191807B1 (en) | Connector for packaging containing medical fluids and packaging for medical fluids | |
EP2152601B1 (en) | Closure cap for a container for receiving fluids, particularly an enteral nutrient solution and container having such a closure cap | |
EP2536377A1 (en) | Closure cap for a receptacle for receiving medical liquids, and receptacle | |
DE19728775C2 (en) | Tamper-evident seal for packaging containing medical liquids | |
EP2247274B1 (en) | Closure cap for containers | |
EP2432529A1 (en) | Drip chamber for an infusion device and infusion device having a drip chamber | |
DE102017119225B4 (en) | Device for storing, conveying or dosing nutritional solutions, liquid medicaments or the like, as well as a method for producing such a device | |
WO2024023082A1 (en) | Closure system for a medicine container, and medicine container comprising a closure system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110704 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140731 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2531103 Country of ref document: ES Kind code of ref document: T3 Effective date: 20150310 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502009010587 Country of ref document: DE Effective date: 20150312 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 707923 Country of ref document: AT Kind code of ref document: T Effective date: 20150315 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20150128 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150428 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150428 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150528 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150429 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502009010587 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20151029 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151203 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151231 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151231 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151203 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 707923 Country of ref document: AT Kind code of ref document: T Effective date: 20151203 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151203 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20091203 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150128 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20231107 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240105 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20241227 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20241227 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20241114 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20241121 Year of fee payment: 16 |